Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Rezolve Joins an Elite Group of Foundational Model Providers Including OpenAI, Anthropic, Meta, xAI, and DeepSeek brainpowa™ Now Empowering Global Brands to Build Custom "Commerce Copilots" on Azure ...
-
Essential3 is the first positive Phase 3 program in essential tremor; ulixacaltamide has received FDA Breakthrough Therapy Designation, with data selected for plenary presentation at AAN 2026Praxis to...
-
MIAMI, FL, April 13, 2026 (GLOBE NEWSWIRE) -- RenX Enterprises Corp. “RenX” (NASDAQ: RENX) (“RenX” or the “Company”), a technology-driven environmental processing and sustainable materials company,...
-
-Trial Combines LIXTE’s LB-100 with Dostarlimab; Results Give Patients New Hope for a Challenging Disease with Limited Therapeutic Options- BOCA RATON, Fla., April 13, 2026 (GLOBE NEWSWIRE) --...
-
WEST HOLLYWOOD, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- VisionWave Holdings, Inc. (Nasdaq: VWAV), a defense and advanced sensing technology company, today announced the completed acquisition of...
-
ATLANTA, April 13, 2026 (GLOBE NEWSWIRE) -- Bitcoin Depot (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced the appointment of Tony Gagliardi as...
-
OSS to deliver rugged AI compute payloads for autonomous, energy systems Initial purchase order valued at over $500,000, with follow-on orders expected to exceed $1 million annually ESCONDIDO,...
-
-- Select findings demonstrate that the use of EXPAREL® (bupivacaine liposome injectable suspension) in outpatient Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA) is associated with...
-
CHANDLER, Ariz. and YUYAO CITY, China, April 13, 2026 (GLOBE NEWSWIRE) -- Microchip Technology (Nasdaq: MCHP), a broadline supplier of semiconductors committed to making innovative design easier...
-
FOSTER CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer,...